Alpa Laboratories Limited
ALPA.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.21B
Close$
$52.93
7.8% downside
Current Fair Value
7.8% downsideOvervalued by 7.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.21 Billion |
|---|---|
| Enterprise Value | $1.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $7.13 |
| Beta | 0.91 |
| Outstanding Shares | 20,008,163 |
Return
| Return on Equity | 2.35% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 33.92 |
|---|---|
| PEG | -37.01 |
| Price to Sales | 0.99 |
| Price to Book Ratio | 0.62 |
| Enterprise Value to Revenue | 1.04 |
| Enterprise Value to EBIT | 22.79 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Alpa Laboratories Limited
457 employees
CEO: Mahendra Singh Chawla Established in 1967 and based in Indore, India, Alpa Laboratories Limited specializes in the development and marketing of a diverse portfolio of finished pharmaceutical dosage forms. Their extensive product range includes ethical, generi...